Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXAGEN INC. Director's Dealing 2024

Sep 4, 2024

33644_dirs_2024-09-04_e4037da0-589f-48f2-8308-e9e23a8e0374.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2024-09-01

Reporting Person: Black Jeffrey G. (Chief Financial Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 27194 Direct